Search
forResearch 10 of 1000+
- Alopecia: from clinic to preclinic and back
- Hair Mesotherapy
- Caractérisation physique et chimique des substances à activité thérapeutique : application aux études de profil de stabilité et de préformulation
- Analytical chemistry studying historical pharmaceuticals and health care formulations
- What should it take to describe a substance or product as 'sperm-safe'
- Price Discrimination Across Indications in the Pharmaceutical Industry: The Case of Finasteride
- Optimal concentration selection of active pharmaceutical ingredients in the cream-mask intended for androgenic alopecia treatment according to experimental results on paramecium caudatum biological model
- Regulation and Implementation of Pharmaceutical and Other Regulations
- Price discrimination across indications in the pharmaceutical industry: The case of finasteride
- A Comprehensive Review on Deep Eutectic Solvents and Its Use to Extract Bioactive Compounds of Pharmaceutical Interest
Learn 2 of 8
All learn results →Community 10 of 50
- Pelage Pharmaceutical Raises 120 million to continue PP405 Research. Link inside.
- Kintor Pharmaceutical’s KX-826 Shows Promising Results in Hair Loss Study
- Cosmo Pharmaceutical (Breezula) fiscal results. Top Line Six month results expected early in the second half of this year.
- JW Pharmaceutical shows superiority of 'JW0061' in hair growth over existing treatments in US
- Pelage Pharmaceuticals Phase 3 Trials for PP405 Start in September 2026
- Pelage Pharmaceuticals posted a tweet about PP405.
- Pelage Pharmaceuticals with an absolute stunner of a molecule
- Pelage Pharmaceuticals’ PP405 and its Impact on Follicular Regeneration to be Presented at the American Academy of Dermatology (AAD) Annual Meeting 2026 28th march
- Pelage Pharmaceuticals’ PP405 and its Impact on Follicular Regeneration to be Presented at the American Academy of Dermatology (AAD) Annual Meeting 2026
- Pelage Pharmaceuticals' PP405 listed on Time Magazine's List of Best Inventions of 2025